Last 47 quarters of trend data · Healthcare · Cannabis
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 1.95 | 0.33 | — | 2.80 | — | — | 0.79 | — | — | 14.81 | — | — | — | — | — | 17.22 | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.56 | 0.33 | 0.74 | 0.90 | 0.85 | 0.64 | 0.51 | 1.07 | 0.70 | 1.02 | 1.30 | 0.73 | 0.58 | 0.91 | 1.57 | 2.12 | 2.01 | 2.57 | 3.99 | 5.48 | 8.03 |
| — | -48.4% | +43.4% | -15.5% | +21.0% | -37.2% | -60.5% | +46.8% | +20.8% | +11.9% | -17.1% | -65.6% | -71.0% | -64.7% | -60.7% | -61.3% | -75.0% | -77.3% | -66.8% | +47.8% | +167.5% | |
| P/B Ratio | 0.45 | 0.25 | 0.47 | 0.62 | 0.78 | 0.47 | 0.35 | 0.57 | 0.41 | 0.56 | 0.72 | 0.41 | 0.39 | 0.39 | 0.49 | 0.71 | 0.72 | 0.77 | 0.99 | 1.38 | 1.67 |
| — | -46.6% | +37.0% | +10.0% | +89.9% | -16.9% | -52.1% | +37.1% | +4.1% | +43.0% | +48.0% | -42.1% | -45.1% | -48.6% | -50.8% | -48.4% | -56.8% | -58.2% | — | +53.4% | +103.5% | |
| P/FCF | — | — | — | — | — | 9.04 | — | — | 4.49 | — | — | 4.31 | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | 8.41 | 2.42 | — | 36.92 | 10.28 | 14.35 | — | — | 1.74 | — | — | — | — | — | — | 6.84 | — | — | — | — | — |
| — | -83.2% | — | — | +490.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 7.01 | — | — | 53.17 | — | — | — | 1.39 | 7.64 | — | — | — | — | — | 14.45 | — | — | — | — | — |
| — | — | — | — | +3720.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 3.7% | 39.2% | 27.4% | 36.7% | 39.8% | 36.9% | 28.1% | 32.3% | 38.5% | 34.1% | 25.5% | 18.4% | -27.7% | -14.3% | 24.8% | 55.1% | 31.3% | 20.0% | 28.5% | 2.0% | 13.5% |
| — | +6.0% | -2.3% | +13.6% | +3.2% | +8.3% | +10.0% | +75.9% | +239.1% | +338.1% | +2.8% | -66.7% | -188.4% | -171.5% | -12.9% | +2645.9% | +132.5% | +92.3% | +124.3% | +102.3% | +109.6% | |
| Operating Margin | -34.1% | 5.0% | -16.4% | -5.4% | 1.5% | -3.0% | -11.6% | -15.9% | 0.6% | -12.3% | -40.3% | -43.7% | -85.5% | -669.9% | -27.5% | 9.4% | -18.8% | -31.3% | -21.8% | -45.2% | -89.0% |
| — | +269.5% | -41.7% | +66.2% | +134.6% | +75.8% | +71.3% | +63.6% | +100.7% | +98.2% | -46.6% | -566.5% | -355.3% | -2038.9% | -25.8% | +120.7% | +78.9% | +47.9% | +89.1% | +69.0% | +57.1% | |
| Net Margin | -9.6% | 99.8% | -1.5% | 31.4% | -47.4% | -8.9% | 64.7% | -53.7% | -12.2% | 6.9% | -72.0% | -43.2% | -71.7% | -651.1% | -19.0% | 12.3% | -13.5% | -7.3% | -12.7% | -4.3% | -104.4% |
| — | +1222.2% | -102.4% | +158.5% | -290.1% | -229.5% | +189.9% | -24.4% | +83.0% | +101.1% | -279.5% | -451.2% | -430.4% | -8803.9% | -49.2% | +386.3% | +87.1% | +62.9% | +97.2% | +97.6% | +44.8% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -5.4% | 22.7% | -0.2% | 5.6% | -10.3% | -1.6% | 11.9% | -7.3% | -1.8% | 1.0% | -10.2% | -5.9% | -11.5% | -52.6% | -1.5% | 1.0% | -1.2% | -0.5% | -0.8% | -0.3% | -5.3% |
| — | +1500.3% | -102.1% | +176.2% | -472.5% | -263.4% | +216.3% | -22.6% | +84.3% | +101.9% | -599.3% | -671.3% | -854.3% | -9577.0% | -79.9% | +484.0% | +77.2% | +82.5% | +99.6% | +97.6% | +57.6% | |
| ROA | -3.7% | 15.7% | -0.2% | 3.7% | -6.7% | -1.1% | 8.3% | -5.2% | -1.4% | 0.8% | -8.6% | -5.3% | -10.2% | -47.4% | -1.3% | 0.9% | -1.1% | -0.5% | -0.7% | -0.2% | -4.6% |
| — | +1476.6% | -102.1% | +170.5% | -372.9% | -239.1% | +197.3% | +1.8% | +86.0% | +101.7% | -544.9% | -669.0% | -863.3% | -9841.3% | -85.9% | +490.3% | +77.0% | +42.3% | +95.3% | +96.9% | +49.3% | |
| ROIC | -17.8% | 0.9% | -2.1% | -0.7% | 0.3% | -0.4% | -1.7% | -2.1% | 0.1% | -1.8% | -5.5% | -5.2% | -12.0% | -47.3% | -1.8% | 0.7% | -1.5% | -2.2% | -1.3% | -2.5% | -3.8% |
| — | +311.3% | -25.2% | +64.6% | +156.5% | +76.7% | +69.2% | +60.3% | +100.8% | +96.2% | -199.6% | -860.3% | -681.9% | -2092.6% | -44.2% | +127.2% | +59.3% | +82.7% | +99.1% | +57.6% | +55.9% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.03 | 0.04 | 0.02 | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | 0.01 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
| — | +58.8% | -9.7% | -25.5% | +72.2% | +6920.7% | +5526.3% | +5726.6% | -16.2% | -43.3% | +11.6% | +25.2% | +162.9% | -96.0% | -97.5% | -93.6% | -46.7% | +42.8% | — | -98.3% | -96.4% | |
| Debt / EBITDA | — | 1.36 | — | 5.41 | 1.42 | 3.41 | — | — | 1.33 | — | — | — | — | — | — | 0.02 | — | — | — | — | — |
| — | -60.2% | — | — | +7.2% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 2.26 | 2.61 | 2.82 | 2.73 | 2.26 | 2.59 | 3.42 | 3.36 | 4.92 | 4.29 | 3.47 | 4.28 | 6.95 | 4.54 | 6.50 | 4.71 | 4.01 | 4.17 | 5.04 | 8.40 | 9.92 |
| — | +0.8% | -17.6% | -18.7% | -54.1% | -39.7% | -1.4% | -21.5% | -29.3% | -5.4% | -46.6% | -9.2% | +73.5% | +8.8% | +29.0% | -43.9% | -59.6% | -69.6% | -24.4% | +215.6% | +69.5% | |
| Quick Ratio | 1.28 | 1.07 | 1.30 | 1.32 | 1.28 | 1.42 | 1.90 | 1.85 | 3.37 | 2.54 | 1.98 | 2.11 | 3.34 | 2.48 | 3.67 | 2.84 | 2.77 | 3.06 | 3.84 | 6.83 | 8.06 |
| — | -24.6% | -31.7% | -28.8% | -62.1% | -44.0% | -4.2% | -12.3% | +0.8% | +2.4% | -46.1% | -25.7% | +20.6% | -19.0% | -4.4% | -58.4% | -65.6% | -72.9% | -42.3% | +245.9% | +138.2% | |
| Interest Coverage | — | 9.85 | — | — | 22.68 | — | -60.97 | -11.86 | — | 55.19 | -233.03 | -327.13 | -264.08 | -3354.52 | -117.84 | 125.32 | -37.35 | -27.17 | -45.04 | -14.72 | -189.96 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OGI stock.
Organigram Global Inc.'s current P/E is 2.0x. The average P/E over the last 2 quarters is 1.6x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Organigram Global Inc.'s current operating margin is -34.1%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Organigram Global Inc.'s business trajectory between earnings reports.